Translational Genomic and Functional Studies of Leukemia
21 – 30 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Building a precision medicine infrastructure at a national level: The Swedish experience
- Contribution to journal › Scientific review
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
- Contribution to journal › Article
-
Mark
Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Novel precision medicine approaches and treatment strategies in hematological malignancies
- Contribution to journal › Scientific review
-
Mark
IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
ETV6::RUNX1-positive leukemia cells in preclinical models.
- Contribution to journal › Article
-
Mark
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
- Contribution to journal › Article
- 2022
-
Mark
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)
- Contribution to journal › Article
-
Mark
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
- Contribution to journal › Article
-
Mark
High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
- Contribution to journal › Article
